HOLLAND & KNIGHT LLP

Lobbying for TAKEDA PHARMACEUTICALS AMERICA, INC. · Pharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate · $50,000.00 income · posted Oct 10, 2025

Lobbying activity 1

Taxation/Internal Revenue Code

Tax reform in 2025.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem